FDA Approves Device to Test Blood Donors for Hepatitis C
July 13, 2007
On Thursday, Abbott Laboratories said the Food and Drug Administration had approved its automated Prism HCV device to test for hepatitis C virus in the blood of potential donors. Already approved to test for hepatitis B, the device replaces a number of manual procedures with a single system, said Kelly Morrison, Abbott spokesperson. By automating labor-intensive steps in the testing process, the system cuts the risk of operator error, Morrison added. The Prism device is now in use in more than 30 countries. Abbott last year signed an agreement with the American Red Cross to supply the organization with Prism systems through 2011.
07.13.2007; Bloomberg News
Black Business Group Criticizes Clinton for Presidential Debate Comments on Federal Funding for HIV/AIDS Programs
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.